Effects of Nasal Ventilation on Cerebral and Pulmonary Function in Orally Intubated Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The passage of air through the nasal cavity generates rhythmic oscillations transmitted by the olfactory bulb to the brain, which induces cerebral activation in functional areas and is associated with better cognitive performance compared to oral breathing. Consequently, the abolition of nasal ventilation in patients intubated via the orotracheal route could have deleterious effects on brain activity. Besides the loss of olfaction, the abolition of nasal ventilation could affect brain activity and respiratory control, consequently altering regional pulmonary ventilation.

The hypothesis of the study is that nasal ventilation through the passage of humidified nasal airflow in patients intubated via the orotracheal route would be associated with modulation of cerebral electrical activity and tissue oxygenation and a modification of regional pulmonary ventilation.

Eligibility criteria

Qualifiers

Age ≥ 18 years old

Hypoxemic acute respiratory failure

Intubation and mechanical ventilation since less than 4 days

PaO2/FiO2 ratio less than 200

Disqualifiers

Central nervous system diseases (stroke, MS, epilepsy)

Psychiatric illnesses (psychosis, depression) (indicated on patient's medical record)

Hemodynamic instability (noradrenalin>2mg/h)

Patient on AME

Trial design

Treatments tested in this trial

  • EEG activity measurement

Treatment groups

22 Participants
are divided into 1 treatment group